Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Novack, Deborah Veis"'
Autor:
Vaira, Sergio, Johnson, Trevor, Hirbe, Angela C., Alhawagri, Muhammad, Anwisye, Imani, Sammut, Benedicte, O'Neal, Julie, Zou, Wei, Weilbaecher, Katherine N., Faccio, Roberta, Novack, Deborah Veis
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2008 Mar 01. 105(10), 3897-3902.
Externí odkaz:
https://www.jstor.org/stable/25461338
Autor:
Ramanadham, Sasanka, Yarasheski, Kevin E., Silva, Matthew J., Wohltmann, Mary, Novack, Deborah Veis, Christiansen, Blaine, Tu, Xiaolin, Zhang, Sheng, Lei, Xiaoyong, Turk, John
Publikováno v:
In The American Journal of Pathology 2008 172(4):868-881
Autor:
Novack, Deborah Veis
Proinflammatory molecules promote osteoclast-mediated bone erosion by up-regulating local RANKL production. However, recent evidence suggests that combinations of cytokines, such as tumor necrosis factor (TNF) plus interleukin-6 (IL-6), induce RANKL-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::803e4db1f78c448dacbd664d79eeef46
https://europepmc.org/articles/PMC5125836/
https://europepmc.org/articles/PMC5125836/
Autor:
Amend, Sarah R., Uluckan, Ozge, Hurchla, Michelle, Leib, Daniel, Novack, Deborah Veis, Silva, Matthew, Frazier, William, Weilbaecher, Katherine N.
Thrombospondin-1 (TSP1), an endogenous antiangiogenic, is a widely expressed secreted ligand with roles in migration, adhesion and proliferation and is a target for new therapeutics. While TSP1 is present in the bone matrix and several TSP1 receptors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bba3cb6a8a87120f92197e9dba552c00
https://europepmc.org/articles/PMC4403870/
https://europepmc.org/articles/PMC4403870/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yang, Chang, Davis, Jennifer L., Zeng, Rong, Vora, Paras, Su, Xinming, Collins, Lynne I., Vangveravong, Suwanna, Mach, Robert H., Piwnica-Worms, David, Weilbaecher, Katherine N., Faccio, Roberta, Novack, Deborah Veis
Inhibitor of apoptosis (IAP) proteins play a central role in many types of cancer, and IAP antagonists are in development as anticancer agents. IAP antagonists cause apoptosis in many cells, but they also activate alternative NF-κB signaling through
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8a6a6239b69fb0a1d1b2da1361c22969
https://europepmc.org/articles/PMC3570610/
https://europepmc.org/articles/PMC3570610/
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.